1 insider bought €41k of shares over the last 90 days, the latest filed 01 Oct 2026.
This page follows insider dealings at Venture Life Group plc as filed with RNS (LSE). Over the twelve months to 18 October 2026, 7 filings were filed, from 3 insiders.
Purchases and sales both appear in the filings: 6 purchases (2 insiders, €307k) and 1 sale (1 insider). No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €70k, bought by Paul McGreevy and made public on 30 June 2026 (0.074% of market cap). Among those who bought: 1 board member and 1 finance chief.
Across the 834 companies tracked on its exchange, the median is 6 filings; at 7 filings, this issuer sits above that mark. Over the whole record (from 2023), the tally stands at 11 purchases and 3 sales.
The latest purchase is recent: it was published 16 days ago, on 1 October 2026. Most trades are made public on the day they happen. The regulation allows three business days to notify a trade (UK MAR).
Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Venture Life Group plc Strong Buy (bullish), based on 1 analysts. Average price target: £1.50.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2024 · cache
14 of 14 declarations
Venture Life Group plc is a company focused on the development and commercialization of health and wellness products. It primarily operates in the UK market.